HCAT
Undervalued by 56.8% based on the discounted cash flow analysis.
Market cap | $393.75 Million |
---|---|
Enterprise Value | $325.09 Million |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $-2.09 |
Beta | 1.87 |
Outstanding Shares | 59,033,536 |
Avg 30 Day Volume | 686,442 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -3.33 |
---|---|
PEG | 21.8 |
Price to Sales | 1.36 |
Price to Book Ratio | 1.13 |
Enterprise Value to Revenue | 1.1 |
Enterprise Value to EBIT | -2.56 |
Enterprise Value to Net Income | -3 |
Total Debt to Enterprise | 0.77 |
Debt to Equity | 0.68 |
No data
No data